NO920377L - Nitrogen-heterocykliske forbindelser - Google Patents

Nitrogen-heterocykliske forbindelser

Info

Publication number
NO920377L
NO920377L NO92920377A NO920377A NO920377L NO 920377 L NO920377 L NO 920377L NO 92920377 A NO92920377 A NO 92920377A NO 920377 A NO920377 A NO 920377A NO 920377 L NO920377 L NO 920377L
Authority
NO
Norway
Prior art keywords
nitrogen
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
NO92920377A
Other languages
English (en)
Norwegian (no)
Other versions
NO920377D0 (no
Inventor
Robert Hugh Bradbury
Martin Paul Edwards
Arnold Harry Ratcliffe
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919102807A external-priority patent/GB9102807D0/en
Priority claimed from GB919110593A external-priority patent/GB9110593D0/en
Priority claimed from GB919113183A external-priority patent/GB9113183D0/en
Priority claimed from GB919116314A external-priority patent/GB9116314D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO920377D0 publication Critical patent/NO920377D0/no
Publication of NO920377L publication Critical patent/NO920377L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO92920377A 1991-02-11 1992-01-28 Nitrogen-heterocykliske forbindelser NO920377L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919102807A GB9102807D0 (en) 1991-02-11 1991-02-11 Nitrogen heterocycles
GB919110593A GB9110593D0 (en) 1991-05-16 1991-05-16 Heterocyclic derivatives
GB919113183A GB9113183D0 (en) 1991-06-18 1991-06-18 Nitrogen compounds
GB919116314A GB9116314D0 (en) 1991-07-29 1991-07-29 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
NO920377D0 NO920377D0 (no) 1992-01-28
NO920377L true NO920377L (no) 1992-08-12

Family

ID=27450623

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920377A NO920377L (no) 1991-02-11 1992-01-28 Nitrogen-heterocykliske forbindelser

Country Status (15)

Country Link
US (1) US5236937A (ja)
EP (1) EP0499415A1 (ja)
JP (1) JPH0592956A (ja)
KR (1) KR920016447A (ja)
AU (1) AU1040992A (ja)
CA (1) CA2060107A1 (ja)
CS (1) CS36192A3 (ja)
FI (1) FI920564A7 (ja)
GB (1) GB9202585D0 (ja)
HU (1) HUT60488A (ja)
IE (1) IE920175A1 (ja)
IL (1) IL100746A0 (ja)
MX (1) MX9200559A (ja)
NO (1) NO920377L (ja)
ZW (1) ZW1492A1 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284954A (en) * 1990-09-10 1994-02-08 Abbott Laboratories Process for the preparation of tetrazoles
GB9121727D0 (en) * 1991-10-14 1991-11-27 Ici Plc Heterocyclic compounds
US5364869A (en) * 1992-03-09 1994-11-15 Abbott Laboratories Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
TW348175B (en) * 1993-01-06 1998-12-21 Hoechst Ag Process for the preparation of biphenyl derivatives
FR2711367B1 (fr) * 1993-10-19 1995-12-01 Roussel Uclaf Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus.
DE4320432A1 (de) * 1993-06-21 1994-12-22 Bayer Ag Substituierte Mono- und Bipyridylmethylderivate
US6455734B1 (en) 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
EP1466904A4 (en) * 2001-12-28 2005-12-14 Takeda Pharmaceutical BIARYL CONNECTION AND ITS USE
US7238717B2 (en) * 2002-05-24 2007-07-03 Millennium Pharmaceuticals, Inc. CCR9 inhibitors and methods of use thereof
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
WO2006078941A2 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Novel sirtuin activating compounds and methods of use thereof
KR101488812B1 (ko) * 2005-04-12 2015-02-02 바이코어 파마 아베 신규한 비시클릭 안지오텐신 ⅱ 아고니스트
DE602006018122D1 (de) 2005-04-12 2010-12-23 Vicore Pharma Ab Neue tricyclische angiotensin-ii-agonisten
JP5202301B2 (ja) 2005-04-12 2013-06-05 ヴィコール・ファルマ・アーベー 新規な三環系アンジオテンシンiiアゴニスト
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治疗胃肠道病症的组成物
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009465A1 (de) * 1978-09-20 1980-04-02 Ciba-Geigy Ag N-(1-(4-Amino-2-chinazolinyl)-3- oder -4-piperidyl-lactame, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
FI903966A7 (fi) * 1989-08-11 1991-02-12 Ici Plc Typpiyhdisteitä
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
EP0453210A3 (en) * 1990-04-19 1993-01-13 Imperial Chemical Industries Plc Pyridine derivatives
CN1034934C (zh) * 1990-06-19 1997-05-21 明治制果株式会社 血管紧张素ii拮抗性吡啶衍生物的制备方法
IE912956A1 (en) * 1990-09-10 1992-03-11 Abbott Lab Angiotensin ii receptor antagonists

Also Published As

Publication number Publication date
CS36192A3 (en) 1992-08-12
FI920564A0 (fi) 1992-02-11
GB9202585D0 (en) 1992-03-25
JPH0592956A (ja) 1993-04-16
IE920175A1 (en) 1992-08-12
KR920016447A (ko) 1992-09-24
AU1040992A (en) 1992-08-13
EP0499415A1 (en) 1992-08-19
IL100746A0 (en) 1992-09-06
US5236937A (en) 1993-08-17
MX9200559A (es) 1992-08-01
FI920564L (fi) 1992-08-12
HU9200268D0 (en) 1992-04-28
CA2060107A1 (en) 1992-08-12
HUT60488A (en) 1992-09-28
ZW1492A1 (en) 1992-09-30
FI920564A7 (fi) 1992-08-12
NO920377D0 (no) 1992-01-28

Similar Documents

Publication Publication Date Title
FI935134A7 (fi) Substituoidut 3-aminokinuklidiinit
FI925100A7 (fi) Substituoituja bifenyylipyridoneja
FI925381A0 (fi) Signaleringsanordningar i ett centralsystem foer cellulaer mobiltelefoni
FI934548L (fi) En pappersarkmaterial foer ett aromatiskt aemne innehaollande roekningsprodukt
MX9100513A (es) Compuestos
NO920377L (no) Nitrogen-heterocykliske forbindelser
FI933549A0 (fi) Lyssnande kontrollkanal i ett cellulaert mobilradiotelefonsystem
FI924956A0 (fi) Multiplexerat elektrohydrauliskt kontrollsystem foer anvaendning i ett submarint produktionssystem
MX9100517A (es) Compuestos
FI921361L (fi) Lagerhus foer ett flerradigt rullager
FI932248L (fi) Hepatit b-vaccinkomposition innehaollande ett gallsyrasalt
FI920840L (fi) Boggie foer raelsfordon
FI89570B (fi) Axelkonstruktion foer ett nyttofordon
FI925980A7 (fi) Bisheterocykliska foereningar
NO933170D0 (no) Heterocykliske forbindelser
FI915200L (fi) Foerfarande foer olineaer signalbehandling i en ekoslaeckare
FI933900L (fi) Heterocykliska foereningar
FI932996A7 (fi) Heterocykliska foereningar
FI920998L (fi) Skaermad hytt i modulkonstruktion
DK106991D0 (da) Dichloranilinforbindelser
TR25953A (tr) SüBSTITüE EDILMIS 2-ARILPIROLLER
FI930356L (fi) Oeverfoeringsfoerfarande foer ett infraroedfjaerrstyrningssystem
FI920668A7 (fi) Oksatsinobentsatsoliyhdisteet
FI940890L (fi) Uusia yhdisteitä
TR26694A (tr) SüBSTITüE EDILMIS 4-HETARIL-PIRAZOLINLER